Medtech 2020 Outlook: Data Reigns Supreme For Device Investors
Executive Summary
2019 was a robust year for device fundraising and the trend will continue this year according to Nooman Haque, managing director of life sciences and healthcare at Silicon Valley Bank’s UK branch. However, medtech companies without a data proposition may find themselves struggling to compete.
You may also be interested in...
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
Angle Files De Novo Submission For Parsortix System In Breast Cancer
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.